About Pathos
AI-enabled drug development built for patients
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- New York City, New York
- Founded
- 2022
- Company type
- Privately Held
Pathos is a clinical-stage, AI-enabled precision oncology biotech.
We’re building the next generation of biopharma, where drug development is driven by AI and Multimodal patient data, not guesswork.
With the largest Multimodal Foundation Model in Oncology as a backbone, we're running an integrated engine that pairs model-driven hypotheses with biological validation and biomarker-driven clinical execution, so the right therapies reach the right patients sooner.
Specialties
- AI
- Biotechnology
- Drug Development
- Oncology
- Precision Medicine
- Cancer Biology
- Data Science
- Machine Learning
- Clinical Trials
- Drug Discovery
- Precision Oncology
- Biopharma
- Pharma
- and Computational Biology
Company locations
New York City, New York, US
Locations listed on the company profile. These may include offices outside the United States, and not every location is hiring.
Business areas
- Artificial Intelligence
- Data Management
- Biotechnology
- Life Science
- Medical
- Big Data
- Artificial Intelligence (AI)
- Therapeutics
On LinkedIn
- Followers
- 8,090
- People linked to this company
- 96
People who list this company on LinkedIn, not a verified employee count. Figures reflect the saved company profile.
Funding raised
446,999,992 USD
Total reported by Crunchbase, in US dollars. This is funding raised, not company revenue or valuation.
Explore the company
Employer category
Other employer
Estimated from the company profile. This category has not been confirmed by the employer.